Skip to main content
. Author manuscript; available in PMC: 2012 May 14.
Published in final edited form as: Vascul Pharmacol. 2011 Dec 3;56(3-4):115–121. doi: 10.1016/j.vph.2011.11.003

Fig. 3.

Fig. 3

Percent changes in diameter of gracilis muscle arterioles in response to cumulative concentration of histamine (1 nM–10 μM) in the presence of high glucose concentration before and after incubations with GFAT inhibitor, azaserine (20 μmol/L) or in combination with NO synthase inhibitor, L-NAME (Panel A). Percent changes in diameter of gracilis muscle arterioles in the presence of glucosamine (5 mmol/L) and in the simultaneous presence of glucosamine and the GFAT inhibitor, azaserine (Panel B). Data are in means±S.E.M, significant differences: * P<0.05.